Background The literature is inconsistent regarding the effect of the presence of chronic physical and mental diseases on cognitive decline in older adults. The objectives of this study were to explore the effect of chronic diseases on subsequent cognitive decline assessed via the Mini Mental State Examination (MMSE) in community living older adults.
Introduction
With the aging of the population, close to 135 million people will be living with dementia in 2050. 1 Cognitive decline and dementia have been associated with a significant global economic and social burden reaching $818 billion (US) worldwide in 2015. 2, 3 According to a report of the Alzheimer's Association (2014), the management of several chronic diseases such as diabetes and hypertension (HTN) may prevent future cognitive decline. 4, 5 Others have also documented a synergistic effect on hospitalizations and mortality in older adults, when cognitive impairment co-occur with either chronic obstructive pulmonary disease (COPD), stroke or heart failure. [6] [7] [8] A review of the literature was conducted in the Medline database (with OVID) using the following keywords: ((Dementia OR cognitive decline) AND (Chronic disease* OR different chronic diseases «keywords»)) AND (systematic review OR meta-analysis). Another research for relevant studies in the elderly was conducted in the same databases and by using snowball strategy. Thirty-three relevant articles were chosen. 7, The revised studies varied substantially in terms of sample size and design: cross-sectional studies (large >400 participants, 13, 11, 26 small <400 participants [32] [33] [34] [35] 39 ), large longitudinal populationbased studies (>400 participants) 13, 15, 18, 19, 23, 24, 29, 31 and small longitudinal clinical studies (<400 participants) 10, 14, 25, 28, 34, 35, 41 and length of follow-up: long (≥5 years, up to several decades) 14, 15, 18, 23, 24, 29, 31 or short (6 months to <5 years).
The studies also used varying measures of cognitive status such as the MMSE alone 13, 15, 26 and other cognitive tests such as the Montréal Cognitive Assessment (MOCA) test, 11 Clinical Dementia Ratings (CDR), 10 Modified MMSE (3MS) 20 and other different neurocognitive measures. 14, 15, 18, 19, 23, 25, 28, 29, [32] [33] [34] [35] 41 The definition of clinically significant cognitive decline also varied between the studies reviewed where some have proposed varying cutoffs: MMSE score <24, 13 cognitive ability screening instrument score <82, 15 Six-Item Screener score <5 18 or the clinical definition of dementia. 24 Furthermore, these studies considered varying numbers of potential confounding factors such as socioeconomic status and chronic diseases. Briefly, an association was reported between low or deteriorating cognitive status and a number of chronic diseases, in adults and the elderly, such as HTN, 7,9-17 stroke, 7, 18, 19 diabetes, 7, [20] [21] [22] [23] [24] COPD, [25] [26] [27] coronary heart disease, 28, 29 heart failure, 8, 30, 31 rheumatoid arthritis, 32, 33 cancer (post-chemotherapy), [34] [35] [36] lymphoma with brain radiotherapy 37, 38 and late life chronic depression. 21, 39, 40, 41 In older adults, there were different degrees of evidence concerning the relationship between cognitive decline and three chronic diseases: stroke, 7,17-19 diabetes 7, 17, [20] [21] [22] [23] [24] and HTN, 7, [9] [10] [11] [12] [13] [14] [15] [16] [17] 21 and poor evidence for all other aforementioned chronic diseases. [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] Given the aging of the population and the increasing prevalence of chronic disorders in this population, we aimed to assess in a large sample of community living older adults, the change in cognitive status over a 1-year period as a function of a number of chronic physical and mental disorders. We used linked administrative and survey data allowing for the control of a number of potential confounding factors and reducing the impact of recall bias thus improving the validity of results reported. This study will add to the current evidence helping to identify which chronic diseases impact cognitive decline in older adults. This will allow health professionals to identify which patient profiles are more at risk for cognitive decline for future management treatment plans.
Methods

Study sample
The sample consisted of individuals participating in the ESA (Étude sur la Santé des Ainés) longitudinal study , which included a representative sample of Quebec Frenchspeaking community living older adults (total number at first interview: n = 2811 older adults).
Briefly, data were collected during an 'at home' interview, by trained professionals, lasting close to 90 minutes on average. Written consent was obtained at the beginning of the interview from each participant. Participants were also asked permission to access their 'Régie de l'Assurance Maladie Québec' (RAMQ) and ministerial databases on medical services and hospitalization files (MED-ECHO). People with an MMSE score of <22 at first interview (T1) were excluded. A total number of n = 2494 older adults were eligible and with available administrative data. Among these participants, 2010 were interviewed again at T2 (1 year after the baseline interview), with the inclusion of all MMSE scores at T2 for this study purposes. The Ethics Committee of the Sherbrooke Geriatric University Institute approved the study. More details can be found elsewhere. 42 
Measures
Cognitive status was measured at the baseline (T1) and at follow-up interviews 1 year later (T2) using the MMSE. The MMSE, which is widely used for the assessment of cognitive function, is a discrete scale with a possible score ranging between 0 and 30, where higher scores reflect better cognitive status. [43] [44] [45] The MMSE assesses the following cognitive spheres: orientation, recall, language, praxis, registration, attention and calculation. 43 It has demonstrated good psychometric properties across samples of community living older adults. [43] [44] [45] The independent study variables included a list of chronic diseases that were captured from the Canadian Chronic Disease Surveillance System (CCDSS) framework with the corresponding International Classification of Diseases (ICD) 9/10 codes. 48, 49 Missing ICD-9/10 codes of these chronic diseases were captured from Public Health Agency of Canada or from other published sources (Table 1) . [46] [47] [48] [49] [50] [51] [52] [53] [54] The presence of baseline chronic diseases in the year prior to first interview (T1) was identified in the RAMQ and MED-ECHO administrative databases. ICD-9 and ICD-10 codes were used to identify the following diseases: HTN, ischemic heart disease, heart failure, asthma, COPD, diabetes, mood and anxiety disorders, other mental health disorders (including schizophrenic disorders and other psychoses, alcohol and drugs dependence), metastatic cancer, solid tumor without metastasis, lymphoma, leukemia, stroke, osteoarthritis, rheumatoid arthritis, other inflammatory and connective tissue diseases and other arthritic conditions. [46] [47] [48] [49] [50] [51] [52] [53] [54] The co-variables included the socio-demographic characteristics: age (categorized as 65-74 vs. ≥75 years old), sex, education level (categorized as primary or secondary vs. post-secondary or university), marital status (categorized as married or not married), and the family annual income (categorized as ≤25 000$ Canadian vs. >25 000$ Canadian).
Analysis
Multivariate linear regressions were used to describe the associations between the independent study variables at baseline and (i) respondent MMSE scores at baseline (T1) (range: [22] [23] [24] [25] [26] [27] [28] [29] [30] and at follow-up (T2) (range: [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 43-45 and (ii) the change in MMSE scores during the 1-year period between T1 and T2. Because a decrease in MMSE scores has a more clinical impact when MMSE is already low, we defined our second dependent variable as the percentage of the change in MMSE scores between T1 and T2 that is:
The β value (non-adjusted and adjusted) and its confidence interval were used as a measure of association. All hypotheses were tested with α value fixed at 5%. We used the IBM SPSS Statistics (version 23; IBM Corporation) for all statistical analyses.
Results
The socio-demographic and clinical characteristics of the study sample of older adults (N = 2010) are presented in Table 2 . The sample mean MMSE score at baseline (T1) reached 28.54 (standard deviation (SD) = 1.54) and at follow-up was 28.55 (SD = 1.71).
Cognitive status measured with the MMSE at T1 (Table 3 ) was positively associated with: higher education level (β value: 0.4), higher income (β value: 0.30), female sex (β value: 0.43) and the presence of osteoarthritis (β value: 0.30). However, MMSE score at T1 was negatively associated with advanced age (β value: −0.26) and the presence of other mental health disorders (β value: −0.39).
Cognitive status measured with the MMSE at T2 (Table 3 ) was positively associated with: higher education level (β value: 0.36), higher income (β value: 0.31) and female sex (β value: 0.52). However, MMSE score at T2 was negatively associated with: advanced age (β value: −0.52) and the presence of other mental health disorders (β value: −0.51).
When looking at the change in MMSE scores during the 1-year follow-up period (Table 4) , the results showed that the presence of stroke (β value: −2.83) and diabetes (β value: −1.06) was significantly negatively associated. Participants aged 75 years and older also had a significant decrease in MMSE scores as compared to those aged between 65 and 74 years (β value: −0.91).
Discussion
Main finding of this study First, the cross-sectional analyses at baseline (T1) and at follow-up (T2) showed a number of similar associations between MMSE scores and socio-demographic factors and chronic diseases. Older participants reported on average lower MMSE scores at T1 and T2. MMSE scores at T1 and T2 were also positively associated with female sex, higher education level and higher income. The presence of other mental health disorders was negatively associated with MMSE scores at T1 and T2, reflecting probably the effect of these mental disorders on the cognitive performance during MMSE. [43] [44] [45] However, a positive association of MMSE scores was found at T1 but not at T2 with osteoarthritis, reflecting probably an inconsistent transversal association.
Second and most importantly, with regards to our second dependent variable reflecting the change in cognitive status over the 1-year period, our study showed that the presence of diabetes and stroke, as well as older age, was associated with a decrease in MMSE scores over time. However, we followed participants for only 1 year underestimating potentially further post-stroke cognitive decline that may increase with longer follow-up and with stroke recurrence. 56, 57 For all other socio-demographic factors and other chronic diseases, there was no significant change in MMSE scores during the 1-year follow-up in our study.
In summary, the results showed that age is consistently associated with both lower cognitive status and cognitive decline. Furthermore, a number of socio-demographic factors such as sex, education and income were associated with cognitive status but not with change in MMSE, suggesting that these factors are associated with baseline cognitive status but not necessarily at an increased rate of cognitive decline. The presence of 'other mental disorders' was associated with MMSE scores at T1 and T2, whereas stroke and diabetes were associated with change in MMSE scores, thus reflecting the important longitudinal relationship of these disorders with subsequent cognitive decline. This is supported by the literature that shows the effect of multiple factors implicated in diabetes such as impaired insulin signaling, increased cholesterol, increasing cerebrovascular inflammation and β-amyloid deposition, leading potentially to cognitive decline and Alzheimer's disease. 5 
What is already known on this topic
Other studies found similar associations with our study. First, concerning cognitive status reflected by MMSE scores, older participants had been reported by other authors to have lower cognitive status, 55 which may be explained by the effect of the aging process. 55 Other studies found also similar results with positive associations between MMSE score and higher revenue 39, 55 and higher education level. 39 In addition, stroke, 11, 19, 39 Second is regarding the longitudinal changes in cognitive status. The literature has shown similar results with our study. A prospective study of 23 572 adults (≥45 years old) also found relatively rapid and permanent cognitive decline post-stroke during 6 years of follow-up. 18 Other studies and reviews have also suggested that ischemic stroke is followed by immediate or late cognitive decline and dementia. 7, 18, 19, 56, 57 Others have also reported a more important cognitive decline in diabetic versus non-diabetic older adults. 7, 20, 21 Another prospective study found similar results, but the association was weakened when adjusting for incident stroke, suggesting a mediating effect of stroke in the association between diabetes and cognitive decline. 23 Heart failure (in adults) 30 and coronary heart disease (in older adults) 28 were positively associated with cognitive decline. Contrary to our results, another clinical samplebased study showed that HTN in older adults was associated with cognitive decline but only in persons with questionable dementia (CDR = 0.5). 10 Another review concluded that midlife HTN is a potential risk factor for late life cognitive impairment, while late life mild HTN might be a protective factor. 9 Contrary to our results, another study reported some degree of relationship between COPD and cognitive decline. According to data from the ACTIVE trial, there was no significant decrease in cognitive processing speed after chemotherapy in older cancer patients. 34 Another clinical study found that some older adults that remitted from depression with normal cognition had subsequent cognitive decline after 1 year. 41 No found study had reported on the cognitive changes in relation to rheumatoid arthritis and asthma.
What this study adds
This study reported on the presence of chronic diseases and the change in cognitive status over a 1-year period in a representative sample of community living older adults. In addition, this study used administrative data linked to health survey information increasing the validity of results by minimizing a number of biases due to recall and confounding. While this study strengthens the relationship between stroke and subsequent cognitive decline in older adults, further research is still needed to explore the mechanisms of post-stroke cognitive decline and dementia. 56, 57 This study also adds to the existing evidence about the relationship between vascular risk factors Table 3 Adjusted β value estimates of MMSE scores at T1 and at T2 as a function of chronic diseases and socio-demographic factors at baseline (before T1)
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Adjusted β value at T1 Confidence interval Adjusted β value at T2 Confidence interval e174 JOURNAL OF PUBLIC HEALTH like diabetes and cognitive decline, although this relationship might be mediated by cerebrovascular disease (like stroke). 17 The absence of statistically significant associations in our study between diseases and the subsequent cognitive decline may in part be due to the fact that we controlled for a number of potential confounding factors and also due to the shorter follow-up period of 1 year. Furthermore, we did not find any significant change in MMSE score in association with either mood or anxiety disorders or with other mental health disorders. The findings of this study also highlight that the determinants associated with cognitive status and with the change in cognitive status are different, which may have implications for interventions aimed at specific modifiable factors. To conclude, future studies should use a longitudinal approach focusing on the relationship between: age, diabetes and stroke and subsequent cognitive decline, while verifying a possible moderating effect associated with the presence of multi-morbidity. Future research should also consider the time of diagnosis to assess whether the decline in cognition associated with these disorders is time-dependent. This would inform of possible time windows of intervention that may delay decline.
Limitations of this study
The results presented should be interpreted while considering certain limitations. First, we followed our participants during a 1-year follow-up period which may have underestimated cognitive decline for future years. Clinical significant changes in cognitive status may be determined with longer follow-up. Furthermore, for older adults with baseline MMSE scores ≥26, the rate of MMSE decline is very slow (<0.5 points/year), whereas the rate is faster, up to four points/year for lower baseline MMSE scores. 58 Thus, MMSE decline may have been more difficult to discern in our study due to the fact that our study sample included community living participants without dementia or in the pre-dementia phase at baseline. Second, the presence of chronic diseases was based on administrative 
Strengths of this study
This study also has a number of strengths. First, the presence of chronic disorders was measured in the RAMQ and MED-ECHO databases during the year prior to baseline interview. The temporal relationship criteria between the presence of chronic diseases and the change in MMSE scores were therefore filled. We controlled for many potential confounding factors including socio-demographic factors. We used administrative data that are based on ICD-9/10 codes of chronic diseases facilitating comparisons [46] [47] [48] [49] [50] [51] [52] [53] [54] and limiting participant recall bias and improving the validity of results as opposed to other studies. In addition, while other cognitive tests (e.g. the MOCA test) could be more sensitive for detecting mild or post-stroke cognitive decline, 59 ,60 the MMSE is still a valid screening tool for cognitive assessment purposes. [43] [44] [45] 60 
Conclusion
Advanced age, stroke and diabetes were associated with subsequent cognitive decline in older adults during a 1-year follow-up after controlling for other chronic diseases and socio-demographic factors. Health professionals should be aware that these disorders can have a significant impact on cognitive decline during a short 1-year period in community living older adults not initially presenting with any cognitive problems and should aim for better treatment and follow-up plan. Future studies should focus on a longer follow-up in order to better ascertain the decrements in cognitive status associated with chronic diseases. 
